Vendor source
Reviewed 11 May 2026
Completeness Strong (67%)
Mia (Acquired by DeepHealth)
Kheiron Medical TechnologiesMia supports radiologists in making the recall decision in breast cancer screening. Available to use in various configurations such as an independent second reader, a concurrent reader or in double reader triage. It also offers an AI-enabled breast positioning and image quality assurance tool: Mia IQ.
Supported by 4 papers
General Information
Product name
Company
Modality
Main task
Not specified
Subspeciality
Disease targeted
Regulatory Information
Pathway:
MDD
Class:
Class IIa
Verified by Health AI Register
Other certifications
Not specified
Evidence & Research
Peer-Reviewed Papers
Prospective evaluation of artificial intelligence integration into breast cancer screening in multiple workflow settings: the GEMINI study
Nature Cancer · Mar 2026
Assessing artificial intelligence in breast screening with stratified results on 306 839 mammograms across geographic regions, age, breast density and ethnicity: A Retrospective Investigation Evaluating Screening (ARIES) study
BMJ Health & Care Informatics · May 2025
Prospective implementation of AI-assisted screen reading to improve early detection of breast cancer
Nature Medicine · Nov 2023
Cost-effectiveness requirements for implementing artificial intelligence technology in the Women’s UK Breast Cancer Screening service
Nature Communications · Sep 2023
Technical Papers
Technical Specifications
Patient population age
Not specified
Input
Input format
Output
Output format
Integration
Deployment
Trigger for analysis
Processing time
Population
Market Presence
On market since
AI Platforms
Resellers
Not specified
Countries present
Paying clinical customers
Not specified
Research/test users
Not specified
Pricing Information
Pricing model
Not specified
Based on
Not specified
Source: Vendor | First published: Jun 9, 2024 | Last updated: May 11, 2026